Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “Balloon”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 181 records · Page 10

Exploring the Potential of Hydrogen as a Lift Gas for Nasa’s Scientific Balloon Program

The United States National Aeronautics and Space Administration (NASA) Balloon Program has a rich history of conducting scientific research in the stratosphere, offering a unique platform for experiments in the near-space environment. One critical component of these high-altitude balloons is the choice of lift gas, which is pivotal to achieving the desired altitude and, thus, mission objectives. Traditionally, helium has been the preferred lift gas due to its inert properties and safety considerations. However, the increasing demand and limited global helium reserves have prompted NASA to explore alternative lift gases, with hydrogen emerging as the most logical choice. Hydrogen boasts several advantages, including its abundant availability, cost-effectiveness, and enhanced lift capability compared to helium. Moreover, it can support a wide range of scientific payloads, enabling extended mission durations and increased payload capacities, ultimately strengthening the program’s scientific potential. However, adopting hydrogen as a lift gas is not without challenges. Safety concerns, especially during the launch and recovery phases, are paramount. NASA and the other major players in the scientific ballooning community have been developing stringent safety protocols and engineering solutions to mitigate these risks. This development includes specialized support systems, leak detection mechanisms, and enhanced launch and recovery procedures. Additionally, environmental considerations must be carefully evaluated. Hydrogen release has the potential to increase concentrations of various greenhouse gases, and its usage must be balanced against the benefits it offers to scientific research and exploration. This paper delves into the ongoing research and development efforts to ensure balloon-based research’s long-term sustainability and its ability to continue pushing the boundaries of scientific discovery. This research demonstrates NASA’s commitment to innovation, safety, and environmental responsibility while maintaining its mission to advance our understanding of the Earth and the cosmos.

balloon↗

Use of Cutting Balloon in the Treatment of Urethral Stricture: A Novel Technique

The peripheral cutting balloon has been used to treat various nonvascular strictures as well as vascular stenosis. In this article, we describe for the first time the use of the cutting balloon in the treatment of patients with urethral stricture. Four patients with bulbar urethral stricture were included in the study. All strictures were successfully dilated with the cutting balloon, and patients were free of symptoms at 6-month follow-up. Cutting-balloon dilatation is a safe, easy-to-perform, and effective treatment for patients with tight urethral strictures.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Cerebrospinal Fluid Enhancement on Fluid Attenuated Inversion Recovery Images After Carotid Artery Stenting with Neuroprotective Balloon Occlusions: Hemodynamic Instability and Blood-Brain Barrier Disruption

Purpose: A rare complication of carotid artery stenting (CAS), prolonged reversible neurological symptoms with delayed cerebrospinal fluid (CSF) space enhancement on fluid attenuated inversion recovery (FLAIR) images, is associated with blood-brain barrier (BBB) disruption. We prospectively identified patients who showed CSF space enhancement on FLAIR images. Methods: Nineteen patients-5 acute-phase and 14 scheduled-underwent 21 CAS procedures. Balloon catheters were navigated across stenoses, angioplasty was performed using a neuroprotective balloon, and stents were placed with after dilation under distal balloon protection. CSF space hyperintensity or obscuration on FLAIR after versus before CAS indicated CSF space enhancement. Correlations with clinical factors were examined. Results: CSF space was enhanced on FLAIR in 12 (57.1%) cases. Postprocedural CSF space enhancement was significantly related to age, stenosis rate, acute-stage procedure, and total occlusion time. All acute-stage CAS patients showed delayed enhancement. Only age was associated with delayed CSF space enhancement in scheduled CAS patients. Conclusions: Ischemic intolerance for severe carotid artery stenosis and temporary neuroprotective balloon occlusion, causing reperfusion injury, seem to be the main factors that underlie BBB disruption with delayed CSF space enhancement shortly after CAS, rather than sudden poststenting hemodynamic change. Our results suggest that factors related to hemodynamic instability or ischemic intolerance seem to be associated with post-CAS BBB vulnerability. Patients at risk for hemodynamic instability or with ischemic intolerance, which decrease BBB integrity, require careful management to prevent intracranial hemorrhagic and other post-CAS complications.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Paget-Schroetter Syndrome Treated with Cutting-Balloon Angioplasty

Here, a case of Paget-Schroetter Syndrome in a 25-year-old guitar player is reported. After thrombolysis, conventional angioplasty failed to dilate the underlying subclavian stenosis both before and after first-rib excision with scalenus anterior and medius division. For the third attempt at angioplasty, a cutting balloon was used, which immediately produced a good result. Venography at 4-year follow-up showed no restenosis and no functional deficit. This case report demonstrates that cutting-balloon angioplasty may be considered when conventional balloon fails and may have greater durability than conventional balloon angioplasty in the treatment of Paget-Schroetter syndrome.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Balloon Blocking Technique (BBT) for Superselective Catheterization of Inaccessible Arteries with Conventional and Modified Techniques

PurposeThe purpose of the study was to retrospectively evaluate the efficacy and safety of the balloon blocking technique (BBT).Materials and MethodsThe BBT was performed in six patients (all males, mean 73.5 years) in whom superselective catheterization for transcatheter arterial embolization by the conventional microcatheter techniques had failed due to anatomical difficulty, including targeted arteries originating steeply or hooked from parent arteries. All BBT procedures were performed using Seldinger’s transfemoral method. Occlusive balloons were deployed and inflated at the distal side of the target artery branching site in the parent artery via transfemoral access. A microcatheter was delivered from a 5-F catheter via another femoral access and was advanced over the microguidewire into the target artery, under balloon blockage of advancement of the microguidewire into non-target branches. After the balloon catheter was deflated and withdrawn, optimal interventions were performed through the microcatheter.ResultsAfter success of accessing the targeted artery by BBT, optimal interventions were accomplished in all patients with no complications other than vasovagal hypotension, which responded to nominal therapy.ConclusionThe BBT may be useful in superselective catheterization of inaccessible arteries due to anatomical difficulties.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Balloon-Occluded Carbon Dioxide Gas Angiography for Internal Iliac Arteriography and Intervention

IntroductionThe usefulness of carbon dioxide (CO{sub 2}) gas digital subtraction angiography (DSA) has been reported for patients with renal insufficiency and allergy to iodinated contrast agents. However, CO{sub 2} gas cannot replace the iodinated contrast agent in all cases owing to some disadvantages. We describe balloon-occluded CO{sub 2} DSA (B-CO{sub 2} DSA) as an improved CO{sub 2} DSA procedure for interventions in the internal iliac artery (IIA) region and compare the quality of images obtained using conventional CO{sub 2} DSA and B-CO{sub 2} DSA.Materials and MethodsB-CO{sub 2} DSA-guided embolization was performed for one case of genital bleeding with an acute anaphylactic reaction to the iodinated contrast agent and for three cases of type II endoleaks after endovascular abdominal aortic aneurysm repair with renal dysfunction. A 9-mm occlusion balloon catheter was placed just after the orifice of the IIA. Then, 10–15 ml of CO{sub 2} gas was injected manually via the catheter with and without balloon occlusion. The quality of sequential digital subtraction angiograms was analyzed based on a scoring criterion.ResultsIn all four cases, image quality was improved with B-CO{sub 2} DSA; the poor quality of images without balloon occlusion was because of reflux of the CO{sub 2} gas.ConclusionsB-CO{sub 2} DSA improves the image quality of CO{sub 2} DSA in the IIA region and is useful for vascular intervention. Level of Evidence: Level IV.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results

Purpose: To report technical success, safety profile and oncological results of balloon-occluded transcatheter arterial chemoembolization using a balloon micro-catheter and epirubicin-loaded polyethylene-glycol (PEG) microsphere (100 ± 25 µm and 200 ± 50 µm) in patients with hepatocellular carcinoma (HCC). Materials and Methods: This is a single-centre, single-arm, retrospective study with 6-month follow-up. Twenty-two patients (Child–Pugh A 68% [15/22], B in 32% [7/22]; age 67.05 ± 14 years) with 29 HCC were treated in 24 procedures. Technical success is defined: ability to place the balloon micro-catheter within the required vascular segment, balloon-occluded arterial stump pressure drops and assessment of microsphere deposition. Laboratory assessment pre/post-procedural and complications were analysed, respectively, according to Common Terminology Criteria for Adverse Events (CTCAEv5) and CIRSE system. Postembolization syndrome (PES) was defined as fever and/or nausea and/or pain onset. Oncological results were evaluated using m-RECIST criteria with CT/MRI imaging at 1 and 3–6 months. In partial responder patients, pre/post-procedural tumour volume was compared. Results: Pre-planned feeder was reached in all cases. Pressure drop average was 51.1 ± 21.6 mmHg. Exclusive target embolization was achieved in 14/24 procedures (58.3%). Laboratory test modifications were all grade 1. 4/24 adverse events occurred (17%): pseudo-aneurysm of the feeder (grade 3), liver abscess (grade 2) and 2 asymptomatic segmentary biliary tree dilatations (grade 2). PES occurred in 8/24 (33%). The complete response at 1 and 3–6 months was 44.8% (13/29) and 52.9% (9/17), respectively. The partial response at 1 and 3–6 months was 55% (16/29) and 4/17 (23.5%), respectively. Among partial responder patients, the average percentage of tumour volume reduction was 64.9 ± 27.3%. Conclusion: Epirubicin-loaded PEG microsphere b-TACE is technically feasible, safe and effective procedure for HCC treatment.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Drug-Eluting Balloon Angioplasty for Juxta-Anastomotic Stenoses in Distal Radiocephalic Hemodialysis Fistulas: Long-Term Patency Results

Purpose: To evaluate long-term primary and secondary patency results of drug-eluting balloon angioplasty for the treatment of juxta-anastomotic stenoses in distal radiocephalic arteriovenous fistulas. Materials and Methods: Thirty-eight patients with juxta-anastomotic stenotic distal radiocephalic arteriovenous fistulas who underwent endovascular treatment with drug-eluting balloons between January 2014 and August 2016 in our interventional radiology department were included in this retrospective study. Color Doppler examination for follow-up was performed 15 days, 6 months, 12 months, 18 months, 24 months, 36 months, and 48 months after the procedure. Kaplan–Meier analysis was used to estimate primary and secondary patency rates. Results: Totally, 42 angioplasty with drug-eluting balloons was performed in 38 patients (20 men and 18 women; mean age 66.42 ± 12.01). Technical and clinical success rate was 100% (42/42). The mean follow-up period was 27.71 months ± 12.98 (range, 1–54 months). The estimated primary patency rates at 6 months were 94.7% (95% CI, 80.9%–99.0%), at 12 months were 81.2% (95% CI, 64.6%–91.4%), at 24 months were 60.7% (95% CI, 43.6%–75.7%), and at 48 months were 53.1% (95% CI, 36.5%–69.1%). The estimated secondary patency rates at 6 months were 97.3% (95% CI, 84.5%–99.8%), at 12 months were 86.5% (95% CI, 70.7%–94.8%), at 24 months were 69.0% (95% CI, 51.8%–82.4%), and at 48 months were 61.7% (95% CI, 44.6%–76.5%). Conclusion: Drug-eluting balloon angioplasty is a useful, effective technique in dysfunctional radiocephalic fistulas due to juxta-anastomotic stenoses. We demonstrated remarkably high primary patency rates at 6, 12, 24, and 48 months.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARα pathway

Highlights: • OEA alleviates intimal hyperplasia induced by balloon injury. • OEA suppresses VSMC proliferation and migration. • OEA modulats VSMC proliferation and migration partly through AMPK- PPARα pathway. Vascular smooth muscle cell (VSMC) proliferation and migration are crucial events in the pathological course of restenosis after percutaneous coronary intervention (PCI). N-oleoylethanolamide (OEA) is a bioactive lipid amide released upon dietary fat digestion with many reported actions. However, the effect of OEA on restenosis after vascular injury remains unknown. Here, we investigated the effects of OEA on intimal hyperplasia after balloon injury in vivo, its effect on VSMC proliferation and migration induced by platelet-derived growth factor (PDGF) stimulation in vitro, and the underlying mechanism underlying these effects. The results showed that OEA-treated rats displayed a significant reduction in neointima formation after balloon injury. In cultured VSMCs, treatment with OEA decreased cell proliferation and migration induced by PDGF. OEA treatment both in vivo and in vitro led to an increase in adenosine monophosphate-activated protein kinase (AMPK) phosphorylation and peroxisome proliferator-activated receptor alpha (PPARα), and a decrease in proliferating cell nuclear antigen (PCNA) and cyclinD1 expression. Pharmacological inhibition of AMPK and PPARα reversed the suppressive effects of OEA on VSMC proliferation and migration, suggesting that the suppressive effect of OEA on VSMC proliferation and migration is mediated through the activation of AMPK and PPARα. In conclusion, our present study demonstrated that OEA attenuated neointima formation in response to balloon injury by suppressing SMC proliferation and migration through an AMPK and PPARα-dependent mechanism. Our data suggests that OEA may be a potential therapeutic agent for restenosis after PCI.

60 APPLIED LIFE SCIENCES↗

The First Detection of an Earthquake From a Balloon Using Its Acoustic Signature

Extreme temperature and pressure conditions on the surface of Venus present formidable technological challenges against performing ground-based seismology. Efficient coupling between the Venusian atmosphere and the solid planet theoretically allows the study of seismically generated acoustic waves using balloons in the upper atmosphere, where conditions are far more clement. However, earthquake detection from a balloon has never been demonstrated. We present the first detection of an earthquake from a balloon-borne microbarometer near Ridgecrest, CA in July 2019 and include a detailed analysis of the dependence of seismic infrasound, as measured from a balloon on earthquake source parameters, topography, and crustal and atmospheric structure. Our comprehensive analysis of seismo-acoustic phenomenology demonstrates that seismic activity is detectable from a high-altitude platform on Earth, and that Rayleigh wave-induced infrasound can be used to constrain subsurface velocities, paving the way for the detection and characterization of such signals on Venus.

58 GEOSCIENCES↗

High- β equilibrium and ballooning stability of the low aspect ratio CNT stellarator

In the paper, the existence and ballooning-stability of low aspect ratio stellarator equilibria is predicted for the Columbia Neutral Torus (CNT) with the aid of 3D numerical tools. In addition to having a low aspect ratio, CNT is characterized by a low magnetic field and small plasma volume. Also, highly overdense plasmas were recently heated in CNT by means of microwaves. These characteristics suggest that CNT might attain relatively high values of plasma beta and thus be of use in the experimental study of stellarator stability to high-beta instabilities such as ballooning modes. As a first step in that direction, here the ballooning stability limit is found numerically. Depending on the particular magnetic configuration we expect volume-averaged β limits in the range 0.9%–3.0%, and possibly higher, and observe indications of a second region of ballooning stability. As the aspect ratio is reduced, stability is found to increase in some configurations and decrease in others. Energy-balance estimates using stellarator scaling laws indicate that the lower β limit may be attainable with overdense heating at powers of 40 to 100 kW. The present study serves the additional purpose of testing VMEC and other stellarator codes at high values of β and at low aspect ratios. For this reason, the study was carried out both for free boundary, for maximum fidelity to experiment, as well as with a fixed boundary, as a numerical test.

70 PLASMA PHYSICS AND FUSION TECHNOLOGY↗

The two-dimensional kinetic ballooning theory for ion temperature gradient mode in tokamak

The two-dimensional (2D) kinetic ballooning theory is developed for the ion temperature gradient mode in an up-down symmetric equilibrium (illustrated via concentric circular magnetic surfaces). The ballooning transform converts the basic 2D linear gyro-kinetic equation into two equations: (1) the lowest order equation (ballooning equation) is an integral equation essentially the same as that reported by Dong et al., [Phys. Fluids B 4, 1867 (1992)] but has an undetermined Floquet phase variable, (2) the higher order equation for the rapid phase envelope is an ordinary differential equation in the same form as the 2D ballooning theory in a fluid model [Xie et al., Phys. Plasmas 23, 042514 (2016)]. The system is numerically solved by an iterative approach to obtain the (phase independent) eigen-value. The new results are compared here to the two earlier theories. We find a strongly modified up-down asymmetric mode structure, and non-trivial modifications to the eigen-value.

70 PLASMA PHYSICS AND FUSION TECHNOLOGY↗

Ballooning theory for micro-tearing mode in tokamak

This paper aims to investigate the impact of magnetic drift on the linear micro-tearing mode by using a kinetic approach to derive a reduced two-field eigen system in real space. Here, since the magnetic drift in real space has derivatives, it is more efficient to solve the mode equations in a Fourier-ballooning representation using the two-dimensional (2D) ballooning transform. The lowest-order eigen system in the Fourier-ballooning representation consists of two integral equations, which are numerically solved using the finite difference method for both eigenvalues and wave functions. The main results will be presented through graphical eigenvalue scans for each parameter. Furthermore, we present a graphical comparison between the predictions of the ballooning theory and GENE gyrokinetic code simulation in the pedestal region.

70 PLASMA PHYSICS AND FUSION TECHNOLOGY↗

Omnigenous stellarators with improved ideal and kinetic ballooning stability

Omnigenity is a property of a magnetic field which ensures confinement of trapped particles. It is a necessary requirement for any high-performance stellarator. After creating an omnigenous equilibrium, one must also ensure reduced transport resulting from kinetic and magnetohydrodynamic (MHD) instabilities. To this end, we leverage the GPU-accelerated DESC optimization suite, which is used to design stable, finite-β omnigenous equilibria with poloidal, toroidal, and helical symmetry, achieving Mercier, ideal ballooning, and as a consequence, improved kinetic ballooning stability. We discover stellarators with second stability, a regime of large pressure gradient where an equilibrium becomes ideal ballooning stable, and demonstrate and explore both using theory and gyrokinetic simulations the connection between ideal and kinetic ballooning stability.

optimization↗

Correlation of the tokamak H-mode density limit with ballooning stability at the separatrix

We show for JET and ASDEX Upgrade, based on Thomson-scattering measurements, a clear correlation of the density limit of the tokamak H-Mode highcon nement regime with the approach to the ideal ballooning instability threshold at the periphery of the plasma. It is shown that the MHD ballooning parameter at the separatrix position αsep increases about linearly with the separatrix density normalized to Greenwald density, n e,sep =n GW for a wide range of discharge parameters in both devices. The observed operational space is found to reach at maximum n e,sep =nGW ≈ 0.4-0.5 at values for α sep ≈ 2-2.5, in the range of theoretical predictions for ballooning instability. This work supports the hypothesis that the H-Mode density limit may be set by ballooning stability at the separatrix.

70 PLASMA PHYSICS AND FUSION TECHNOLOGY↗

SU-GG-T-49: Real Time Dose Verification for Novel Shielded Balloon Brachytherapy

Purpose: The validation of a novel approach for reducing skindoses to an acceptable level during Accelerated Partial Breast Irradiation (APBI) when the balloon-to-skin distance is inadequate (less than 7 mm) is reported. The study uses a real time dose verification method for a metallic shielded balloon applicator using scintillation fiber technology. Method and Materials: Partial shielding of the radiationdose to the skin using iron or other ferrous powder could enable the extension of APBI to some patients. With small external and pre-determined magnetic fields (<few Gauss), the metallic elements deposition can be controlled on the inner surface of a balloon. Geant4 simulations were used to generate an attenuation dose curve for various radiation lengths after cross-calibration with dedicated data acquired at Jefferson Lab. Some powder was then injected into various inflated MammoSite and rectal balloons within realistic breast and torso phantoms of differing sizes. The dose on the external surface of the skin was measured from a 6.1 Ci {sup 192}Ir of a GammaMed 12i afterloader unit, with a MOSFET,ion chamber and scintillating fiber array detectors. Results: Realistic Monte Carlo simulation studies for the amount and distribution of the required shielding material were compared to dedicated phantom data. A decrease of the skindose was measured to an acceptable level (~350-450 cGy) during standard breast Brachytherapy treatments with relatively weak magnetic fields. Additional measurements provided negligible corrections (< few %) on the saline water density from the suspended ironpowder.Conclusion: This project opens the possibility to increasing the survival expectancy and minimizing negative side effects during brachytherapy treatments, as well as improving cosmetic outcome for all APBI patients. The proposed method may also be used in other procedures for brain, heart, rectal, or vaginal cancers.

61 RADIATION PROTECTION AND DOSIMETRY↗

TU-AB-201-07: Image Guided Endorectal HDR Brachytherapy Using a Compliant Balloon Applicator

Purpose: High dose rate endorectal brachytherapy is an option to deliver a focal, high-dose radiotherapy to rectal tumors for patients undergoing non-operative management. We investigate a new multichannel, MR compatible applicator with a novel balloon-based design to provide improved treatment geometry. We report on the initial clinical experience using this applicator. Methods: Patients were enrolled on an IRB-approved, dose-escalation protocol evaluating the use of the anorectal (AR-1) applicator (Ancer Medical, Hialeah, FL), a multichannel applicator with two concentric balloons. The inner balloon supports 8 source lumens; the compliant outer balloon expands to separate the normal rectal wall and the source lumens, yet deforms around a firm, exophytic rectal mass, leading to dose escalation to tumor while sparing normal rectum. Under general anesthesia, gold fiducial markers were inserted above and below the tumor, and the AR applicator was placed in the rectum. MRI-based treatment plans were prepared to deliver 15 Gy in 3 weekly fractions to the target volume while sparing healthy rectal tissue, bladder, bowel and anal muscles. Prior to each treatment, CBCT/Fluoroscopy were used to place the applicator in the treatment position and confirm the treatment geometry using rigid registration of the CBCT and planning MRI. After registration of the applicator images, positioning was evaluated based on the match of the gold markers. Results: Highly conformal treatment plans were achieved. MR compatibility of the applicator enabled good tumor visualization. In spite of the non-rigid nature of the applicators and the fact that a new applicator was used at each treatment session, treatment geometry was reproducible to within 2.5 mm. Conclusions: This is the first report on using the AR applicator in patients. Highly conformal plans, confidence in MRI target delineation, in combination with reproducible treatment geometry provide encouraging feedback for continuation with dose escalation in these patients.

60 APPLIED LIFE SCIENCES↗

SU-F-T-45: Dosimetric Effects of Saline Filled Balloons During IORT Using Xoft Electronic Brachytherapy

Purpose: The portability of Xoft Axxent Electronic Brachytherapy (EBx) System has made it a viable option for intraoperative radiation therapy (IORT) treatment of early-stage breast cancer. The low energy (50kVp) of the X-ray source makes the shielding easy, but also means its dose distribution is sensitive to the medium’s composition. Current treatment planning systems (TPS) typically assume homogenous water for brachytherapy dose calculations, including the pre-calculated atlas plans for the Xoft IORT cases. However, Xoft recommends using saline to fill the balloon applicator. This study investigates the dosimetric difference due to the increased effective atomic number (Zeff) from water (7.42) to saline (7.56). Methods: The diameter of the balloon applicators ranges from 3–6cm, with 4cm being most frequently used. For the 4-cm and 6-cm diameter applicators, MCNP Monte Carlo program was used to calculate the dose at the surface (Ds) of the middle section of the balloon and 1 cm away (D1cm) for water- and saline-filled balloons: one plan with a single dwell at the center and another with multiple dwells as in the atlas plans. The single dwell plan is a simple estimation of the dosimetry, while the atlas plan is representative of the actual dose distribution. Results: The single-dwell plan showed a 5.1% and 6.1% decrease in Ds for the 4- and 6-cm applicators, respectively, due to the saline. The atlas plan showed similar Results: 4.8% and 6.4% decrease, respectively. The decrease in D1cm is 4.3%–5.2% and 3.3%–5.3s% in the single-dwell and atlas plans, respectively, for the 4- and 6-cm applicator. Conclusion: The dosimetric effect introduced by saline is on the order of 5%. This effect should be taken into account during both treatment planning and patient outcome studies.

60 APPLIED LIFE SCIENCES↗